By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Seattle  Washington    U.S.A.
Phone: n/a Fax: n/a



Start Up

Company News
PhaseRx (PZRX) Reports Second Quarter 2017 Financial Results And Provides Corporate Update 8/10/2017 1:47:08 PM
PhaseRx (PZRX) Reports First Quarter 2017 Financial Results and Provides Corporate Update 5/12/2017 10:11:02 AM
PhaseRx (PZRX) Receives Positive Opinion For Orphan Drug Designation For PRX-OTC From EMA 4/25/2017 7:02:09 AM
PhaseRx (PZRX) Reports Fourth Quarter And Full Year 2016 Financial Results And Provides Corporate Update 3/27/2017 9:33:51 AM
PhaseRx (PZRX) Receives Orphan Drug Designation From FDA For PRX-OTC For The Treatment Of Ornithine Transcarbamylase Deficiency 11/28/2016 6:55:16 AM
PhaseRx (PZRX) Announces Positive Safety Results From Large Animal Study With Hybrid mRNA Delivery Technology 11/9/2016 12:03:39 PM
PhaseRx (PZRX) Reports Third Quarter 2016 Financial Results And Provides Corporate Update 11/8/2016 11:28:18 AM
PhaseRx (PZRX) To Present Company Overview At Upcoming Investor Conferences 10/11/2016 10:19:58 AM
PhaseRx (PZRX) To Present At The 2016 Aegis Growth Conference 9/14/2016 10:11:58 AM
PhaseRx (PZRX) Appoints Peggy Phillips To Board Of Directors 8/23/2016 8:25:27 AM